Lumida
/NNOX
⌘K
Nano-X Imaging Ltd

Nano-X Imaging Ltd

NNOX
$0.72USD-0.86%-0.01 today

MARKET CAP

56.9M

P/E (TTM)

FWD P/E

DAY RANGE

$1 – $1

52W RANGE

$1
$5

AI Summary

Stalk
TrimMedium

NNOX remains in a Stage 4 decline with confirmed lower highs and lower lows under declining EMAs. The recent volume-backed bounce from extreme oversold conditions has provided relief but not reversed the downtrend. Price is extended below the 9/21/50-day EMA cluster, and the speculative approach favors trimming into rallies toward these overhead EMAs rather than initiating new shorts at current levels.

  • Q1 revenue up 54% YoY to $4.3M, driven by teleradiology services
  • 360 signed deployment agreements signal multi-year growth potential
  • Net loss widened to $14.3M in Q1, with a $2.6M gross loss
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$1.3M$8.6M$9.9M$11.3M$13.0M
YoY %+557.8%+15.5%+13.9%+15.4%
P / Sales537.6x43.4x36.8x37.4x13.9x
EV / Sales541.0x43.3x33.4x35.8x11.9x
Gross Profit, Adj.$-1.5M$-6.9M$-6.6M$-10.6M$-12.8M
YoY %-355.0%+4.2%-60.9%-20.5%
Margin %-116.0%-80.2%-66.6%-94.0%-98.2%
EV / Gross Profit-466.6x-54.0x-50.2x-38.1x-12.1x
EBITDA, Adj.$-59.3M$-55.3M$-43.4M$-45.0M$-49.0M
YoY %-35.6%+6.7%+21.6%-3.8%-8.9%
Margin %-4544.9%-644.9%-437.7%-398.9%-376.4%
EV / EBITDA-11.9x-6.7x-7.6x-9.0x-3.2x
EBIT$-61.6M$-117.7M$-62.6M$-56.7M$-78.2M
YoY %-40.1%-91.2%+46.8%+9.3%-37.9%
Margin %-4720.7%-1372.2%-631.9%-502.9%-600.8%
EV / EBIT-11.5x-3.2x-5.3x-7.1x-2.0x
Net Income$-61.8M$-113.2M$-60.8M$-53.5M$-75.0M
YoY %-41.0%-83.2%+46.3%+11.9%-40.2%
Net Margin-4739.1%-1320.2%-613.6%-474.3%-576.1%
EPS (GAAP)-$1.28-$2.17-$1.08-$0.91-$1.16
YoY %-4.1%-69.5%+50.2%+15.7%-27.5%